Reviewed by: Michael Spear, MD; Kim Rutherford, MD; and Steve Dowshen, MD
In the womb, the pathway of your baby’s blood circulation is different than it is after birth.
In the uterus, a baby’s circulation bypasses the lungs. The lungs are not needed to exchange oxygen because the placenta (the organ that nourishes and protects your developing baby) supplies the baby with oxygen through the umbilical cord. The pulmonary artery – which, after birth, will carry blood from the heart to the lungs – instead sends blood directly back to the heart through a fetal blood vessel called the ductus arteriosus.
Normally, when a baby is born and begins to breathe air, his circulatory system quickly adapts to the outside world. The pressure in the lungs changes as air enters and inflates the lungs. As a result, the ductus arteriosus, which previously supplied the fetal heart with blood, permanently closes. Blood returning to the heart from the body can now be pumped into the lungs, where oxygen and carbon dioxide are exchanged. The blood is then returned to the heart and pumped back out to the body in an oxygen-rich state.
However, in a baby with PPHN, also sometimes referred to as Persistent Fetal Circulation, the fetal circulatory system doesn’t “switch over.” The ductus arteriosus remains open, and the baby’s blood flow continues to bypass the lungs. Even though the baby is breathing, oxygen in the breathed air will not reach the bloodstream. Because the blood returning from the body is unable to enter the lungs properly – and instead flows through the still-open ductus arteriosus – it returns to the heart in an oxygen-poor state. This condition is known as persistent fetal circulation, or PFC.
“The baby’s circulation has not made the normal transition from fetal circulation to normal newborn circulation, because pressure in the lungs is increased and this causes distress,” says Neal Cohn, MD, a pediatrician. Depending on the degree of PPHN causing the persistent fetal circulation, the oxygen in the air your baby breathes into his lungs is not adequately picked up and carried by the blood to other areas of the body that need it (such as the brain, kidneys, liver, and other organs). These organs soon become stressed from lack of oxygen.
PPHN sometimes develops as the result of another event during delivery or from a disease or congenital condition affecting the newborn (usually one that either directly affects the lungs or oxygen supply to the baby before or during birth). Often, however, PPHN occurs as an isolated condition, and its cause is not known. It is usually seen soon after birth, often within 12 hours after birth. PPHN occurs in approximately one in 700 births.
In an otherwise healthy newborn, the cause of PPHN is usually unknown. Some researchers believe that stress while the baby is in the uterus (associated with certain pregnancy complications, such as maternal diabetes, high blood pressure or anemia, or delivery after 40 weeks) may increase the risk of developing PPHN. Certain SSRI antidepressants such as Prozac and Zoloft, taken during pregnancy have also been linked to the occurance of PPHN. PPHN may occur with certain diseases or congenital conditions of the infant that affect the lungs in some way. Meconium aspiration syndrome, anemia, severe pneumonia, infection, hypoglycemia (low blood sugar), and birth asphyxia (when the baby is deprived of oxygen during a complicated delivery) have all been associated with PPHN.
These conditions may cause the pressure in the blood vessels leading to the lungs to increase to the point where the baby’s blood continues to bypass the lungs after birth, resulting in PFC. These conditions are often temporary and reversible, with intensive care and time for the lungs and body to heal. Certain congenital conditions that result in immature or incomplete lung development (such as diaphragmatic hernia) may also be associated with PPHN.
The following signs and symptoms may indicate a baby has PPHN:
Sometimes when examining a baby with PPHN, the doctor will hear a heart murmur (an extra or abnormal heart sound). With PPHN, a baby may also continue to have low oxygen levels in the blood while receiving 100% oxygen.
For any newborn having difficulty breathing and showing signs of poor oxygen delivery to the body’s tissues, several tests will be performed to determine possible causes. Various imaging and laboratory tests can help determine if a baby has PPHN.
Imaging tests will be done to get a better look at the lungs, heart, and circulation, and to check for other possible causes of the baby’s problems:
Laboratory tests can also assist doctors in making a diagnosis of PPHN:
A doctor who specializes in newborn problems, called a neonatologist, will direct the treatment for a child with PPHN. Babies with PPHN usually need to be cared for in a neonatal intensive care unit (NICU). NICUs are usually found in larger hospitals or children’s hospitals.
The first step in PPHN treatment is to maximize the amount of oxygen delivered to the baby’s lungs (and, in turn, to the blood), so 100% oxygen will be given through a tube inserted directly into the baby’s trachea (windpipe). The oxygen is administered by a mechanical ventilator, which does the work of breathing for the baby. This treatment is given in conjunction with other treatments for the illnesses that may have contributed to the initial development of PPHN (such as low blood sugar, pneumonia, or other infections).
If your child has PPHN caused by a lung problem, his breathing rate may be set at a higher than usual rate and pressure through the mechanical ventilator. This is known as high- frequency oscillatory ventilation (HFOU). This ventilation technique improves oxygen delivery to the lungs, reduces acid buildup in the blood, and often helps open up the blood vessels leading the lungs – thus allowing more blood to flow to the lungs. Because PPHN is worsened by narrowed lung blood vessels and raised acid levels in the body (a condition called acidosis), sodium bicarbonate may also be given with this form of ventilation to lower acid levels and help dilate blood vessels.
Recent research shows that supplying inhaled nitric oxide to babies with PPHN may also be successful. Nitric oxide has been shown to have a relaxing effect on contracted lung blood vessels, thus improving blood flow to the lungs in some babies with PPHN.
If other methods can’t reverse the PPHN and raise the baby’s oxygen levels to the necessary range, a type of intensive procedure called extracorporeal membrane oxygenation (ECMO) may be needed. ECMO requires major surgery, is complicated to monitor, and has potentially serious side effects associated with it. It is reserved for the sickest babies who are not responding to other forms of treatment.
The ECMO machine acts as an artificial heart and lung for the baby for several days while the baby’s lungs heal and recover. Although ECMO is very successful in treating PPHN, fewer than 100 hospitals (mostly children’s hospitals) in the United States have facilities that can provide this treatment.
PPHN is a serious condition and intensive monitoring and treatment are critical. Even with prompt recognition and treatment, an infant with PPHN may continue to supply an inadequate amount of oxygen to the body’s tissues, resulting in shock, heart failure, brain hemorrhage, seizures, kidney failure, multiple organ damage, and possibly even death.
Some causes of PPHN are treatable and reversible; others are associated with a poor survival rate, even if nitric oxide and ECMO are used. In some newborns with PPHN, the lungs are too diseased or malformed to heal adequately, even if the baby stays on ECMO for a longer period of time.
Periods of inadequate oxygenation can have long-term effects on infants who survive PPHN, such as bronchopulmonary dysplasia (a chronic lung disease associated with scarred, stiffened lungs) and breathing difficulties. Seizure disorders, developmental delay, and neurological deficits may also be seen.
For several weeks following treatment, infants who’ve had PPHN may not be able to take feedings by mouth. A temporary feeding tube may have to be inserted into the baby’s nose, or for longer-term feeding problems, directly into the stomach through the skin on the abdomen. Feeding tubes will be needed if the baby cannot eat enough to meet his nutritional requirements for growth.
Hearing problems are another common condition associated with PPHN. If your child had PPHN, he will probably need to be evaluated by a hearing specialist during early childhood to check for hearing loss, and the development of his speech will also need to be followed closely.
Medical treatments such as high frequency ventilation, nitric oxide, and ECMO have significantly decreased the percentage of children who die from PPHN. Fifteen years ago, almost half of infants diagnosed with PPHN died; today, less than 20% of infants with PPHN die, and only about one fifth of surviving infants experience long-term physical or developmental complications.
If you took Prozac, fluoxetine, Zoloft, sertraline or any other SSRI antidepressant during pregnancy and your child was born with a PPHN related birth defect, we encourage you to contact an SSRI litigation attorney at our law firm immediately. It may be too late to recover from the devastating effects of SSRI antidepressants, but an experienced products liability attorney at the Willis Law Firm can assist you in a legal action against the makers of the SSRI prescribed. You are not alone. Join other PPHN birth defect victims and their families in speaking up and fighting for your legal rights.
Please fill out our free online legal evaluation form and we will contact you within 24 hours. Please keep in mind that certain states have statutes of limitation that limit the amount of time you have to file a lawsuit or seek legal action. Contact our law firm immediately so that we may explain the rights and options available to you and your family.